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Background/Introduction
A patent left internal mammary artery (LIMA) graft
challenges the protective effects of cold blood cardiople-
gia in patients undergoing re-operative aortic valve
replacement (AVR).
Aims/Objectives
This study presents the results of our approach to myo-
cardial protection in a series of consecutive patients with
previous coronary artery bypass (CAB) undergoing AVR.
Method
Between 2006 and 2014, 72 patients met criteria for inclu-
sion. Out of these 72, 59 had previous CAB and 13 had
CAB + AVR. The surgical procedures performed in these
series included 50 AVR and 22 AVR + CAB. Myocardial
protection was delivered using mild systemic hypothermia
and continuous cold blood retrograde and intermittent
antegrade cardioplegia, avoiding any manipulation of the
LIMA graft. Pre-operative demographics, operative char-
acteristics, in-hospital complications and 30-day mortality
were collected according to Society of Thoracic Surgeons
(STS) standards.
Results
The cohort was predominately male (89%) and diabetic
(58%) with an average age of 74 ± 8.3. Patients observed
improved outcomes compared to STS predicted risk in
Mortality (2.7% vs 6.5%), Stroke (1.4% vs 2.6%),
Re-operation (6.8% vs 11.2%), Prolonged Ventilation
(9.6% vs 21.4%), Renal Failure (1.4% vs 10.0%) Deep
Sternal Wound Infection (0.0% vs 0.8%) and Length of
stay >14 days (2.7% vs. 32.5%). More patients had a
length of Stay >6 days than Predicted (46.6% vs 21.6%).
The STS does not provide a predicted risk for myocar-
dial infarction. The actual rates of complications were
lower than expected in five of the provided categories.
The 1-, 3-, 5-, and 8-year mortality rates were 4.5%
(n = 3/69), 9.8% (n = 5/51), 20.0% (n = 6/30), and
45.5% (n = 5/11) respectively.
Discussion/Conclusion
In this series avoiding the manipulation of a patent
LIMA graft was associated with a low morbidity and
complication rate, including myocardial infarction, when
compared to the predicted STS risk. This has become
our preferred approach when performing re-operative
surgery on patient with patent LIMA.
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